Corrigendum

This article in the July 2015 issue contained errors from the authors. These are listed below.
The sentence "Randomized, double-blind, controlled clinical trials..." Should be read as "A randomized, double-blind, controlled clinical trial has demonstrated...".
Page 163, paragraph 3 as a whole should be read: "The findings of the phase III study by Goldstein et al mentioned above have also been republished with additional details in 2012 (Goldstein and Smith, 2012). Treatment-emergent AEs (mostly transient mild to moderate application-site reactions) were frequent in both groups, reported by 50% of patients receiving active treatment as well as 44% of those receiving placebo."
Page 163, paragraph 4, line 46 should be read: "An open-label extension of the same study"

Source: Therapeutic Advances in Neurological Disorders - October 27, 2015 Category: Neurology Tags: Corrigendum Source Type: research